2014 Fiscal Year Final Research Report
Cytokine-targeted therapy of scleroderma
| Project/Area Number |
24591644
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Dermatology
|
|---|
| Research Institution | University of Fukui (2013-2014)
Kanazawa University (2012) |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Keywords | 強皮症 / 線維化 / サイトカイン |
|---|
| Outline of Final Research Achievements |
To compare the roles of Th1, Th2, and Th17 cytokines, we applied bleomycin-induced scleroderma model to mice deficient for interferon (IFN)-γ, interleukin (IL) -4, and IL-17A. The loss of IL-17A significantly attenuated bleomycin-induced skin fibrosis, whereas deficiency of IFN-γ or IL-4 did not. The leukocyte infiltration and mRNA expression levels of TGF-β and CTGF in the bleomycin-injected skin were significantly reduced in IL-17A-deficient mice. Bleomycin injection stimulated the differentiation of naive T cells into Th17 cells and increased IL-17 expression in the skin. Cell lines of skin fibroblasts expressed increased TGF-β, CTGF, and collagen by the addition of IL-17A. IL-17A, a representative Th17 cytokine, plays a dominant role during the development of skin fibrosis. That is, bleomycin injection induces IL-17A production and increased IL-17A likely stimulates collagen production from fibroblasts probably via cytokine production such as TGF-β and CTGF in mice.
|
| Free Research Field |
全身性強皮症
|
